OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 16, 2020
The new facility at the company’s San Diego, CA, site will be for late phase and commercial CGMP manufacturing.
October 15, 2020
Recent data, from BIA and Clarivate, has revealed that investment in UK biotech continues to be strong.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
September 09, 2020
The investment at its Madison, WI, facility will expand MilliporeSigma’s capacity for high-potent active pharmaceutical ingredient production and allow for continuous flow manufacturing of ADCs.
The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.
September 02, 2020
The companies have signed a definitive agreement to acquire a majority stake of PCI Pharma Services.
August 31, 2020
The new facility, located in Lenexa, KS, will rapidly expand production of viral transport media.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 01, 2020
Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine production.